Paper6791675
In vitro sensitivity of human ovarian tumours to chemotherapeutic agents.
Wilson AP and 1 other. Br J Cancer, 1981. Cited by 34 papers, by iCite.
Cite this record
ConductScience Library. In vitro sensitivity of human ovarian tumours to chemotherapeutic agents. Papers, record 6791675. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6791675
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics13
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Ovarian Neoplasms | Major topic |
| Alkylating Agents | |
| Antimetabolites, Antineoplastic | |
| Cell Survival | |
| Cells, Cultured | |
| Dactinomycin | |
| Drug Evaluation, Preclinical | |
| Drug Resistance | |
| Drug Therapy, Combination | |
| Female | |
| Fluorouracil | |
| Humans | |
| Thiotepa |
Source PubMed
References27
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1139861 | Pharmacokinetics of actinoymcin D in patients with malignant melanoma. | Clin Pharmacol Ther | 1975 | https://conductscience.org/library/papers/1139861 | PubMed |
| 2 | 4462060 | Assessment of an in vitro screening test of cytotoxic agents in the treatment of advanced malignant disease. | Oncology | 1974 | https://conductscience.org/library/papers/4462060 | PubMed |
| 3 | 1156513 | Assay of anti-cancer drugs in tissue culture: conditions affecting their ability to incorporate 3H-leucine after drug treatment. | Br J Cancer | 1975 | https://conductscience.org/library/papers/1156513 | PubMed |
| 4 | 809049 | Fresh explant culture of human tumours in vitro and the assessment of sensitivity to cytotoxic chemotherapy. | Br J Cancer | 1975 | https://conductscience.org/library/papers/809049 | PubMed |
| 5 | 1175172 | Preliminary pharmacokinetic model for adriamycin (NSC-123127). | Cancer Chemother Rep | 1975 | https://conductscience.org/library/papers/1175172 | PubMed |
| 6 | 850579 | Single agent vs combination chemotherapy in the treatment of ovarian cancer. | Obstet Gynecol | 1977 | https://conductscience.org/library/papers/850579 | PubMed |
| 7 | 889590 | Pharmacokinetics and metabolism of vinblastine in humans. | Cancer Res | 1977 | https://conductscience.org/library/papers/889590 | PubMed |
| 8 | 872088 | Pharmacokinetics of vindesine and vincristine in humans. | Cancer Res | 1977 | https://conductscience.org/library/papers/872088 | PubMed |
| 9 | 890697 | Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma. | Cancer Treat Rep | 1977 | https://conductscience.org/library/papers/890697 | PubMed |
| 10 | 597362 | Use of high dose corticosteroids in patients with inoperable brain tumours. | J Neurol Neurosurg Psychiatry | 1977 | https://conductscience.org/library/papers/597362 | PubMed |
| 11 | 413551 | In vitro studies with hexamethylmelamine. | Biochem Pharmacol | 1977 | https://conductscience.org/library/papers/413551 | PubMed |
| 12 | 348078 | Patterns of resistance and therapeutic synergism among alkylating agents. | Antibiot Chemother (1971) | 1978 | https://conductscience.org/library/papers/348078 | PubMed |
| 13 | 95953 | In vivo studies with hexamethylmelamine. | Eur J Cancer (1965) | 1978 | https://conductscience.org/library/papers/95953 | PubMed |
| 14 | 688279 | Plasma levels and urinary excretion of filterable platinum species following bolus injection and iv infusion of cis-dichlorodiammineplatinum(II) in man. | Cancer Treat Rep | 1978 | https://conductscience.org/library/papers/688279 | PubMed |
| 15 | 698034 | A procedure for monitoring cyclophosphamide and isophosphamide in biological samples. | Br J Clin Pharmacol | 1978 | https://conductscience.org/library/papers/698034 | PubMed |
| 16 | 498174 | Pharmacokinetics and metabolism of chlorambucil in man: a preliminary report. | Cancer Treat Rev | 1979 | https://conductscience.org/library/papers/498174 | PubMed |
| 17 | 93985 | Bleomycin pharmacokinetics in man. II. Intracavitary administration. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/93985 | PubMed |
| 18 | 6105478 | In-vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. | Lancet | 1980 | https://conductscience.org/library/papers/6105478 | PubMed |
| 20 | 5702360 | Chemotherapy in the treatment of advanced pelvic malignant disease with special reference to ovarian cancer. | J Obstet Gynaecol Br Commonw | 1968 | https://conductscience.org/library/papers/5702360 | PubMed |
| 21 | 4193360 | In-vitro screening test for human malignant tumours before chemotherapy. | Lancet | 1970 | https://conductscience.org/library/papers/4193360 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 6849794 | A short-term in vitro test for tumour sensitivity to adriamycin based on flow cytometric DNA analysis. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6849794 | PubMed |
| 6540594 | Ovarian carcinoma cells in culture: assessment of drug sensitivity by clonogenic assay. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6540594 | PubMed |
| 6409137 | Clinical correlates of in vitro drug sensitivities of ovarian cancer cells. | Br J Cancer | 1983 | https://conductscience.org/library/papers/6409137 | PubMed |
| 6381380 | The human tumor colony-forming chemosensitivity assay: a biological and clinical review. | Invest New Drugs | 1984 | https://conductscience.org/library/papers/6381380 | PubMed |
| 6197986 | A comparison of three assays used for the in vitro chemosensitivity testing of human tumours. | Br J Cancer | 1984 | https://conductscience.org/library/papers/6197986 | PubMed |
| 4063134 | DNA index of ovarian carcinomas from 56 patients: in vivo in vitro studies. | Br J Cancer | 1985 | https://conductscience.org/library/papers/4063134 | PubMed |
| 4040769 | Cystic fluid-platinum kinetics in ovarian cancer patients: relevance to cis-dichlorodiammine platinum (II) sensitivity testing in vitro. | Br J Cancer | 1985 | https://conductscience.org/library/papers/4040769 | PubMed |
| 3435704 | cis-platinum and ovarian carcinoma. In vitro chemosensitivity of cultured tumour cells from patients receiving high dose cis-platinum as first line treatment. | Br J Cancer | 1987 | https://conductscience.org/library/papers/3435704 | PubMed |
| 3219277 | The treatment of intraperitoneal malignant disease with monoclonal antibody guided 131I radiotherapy. | Br J Cancer | 1988 | https://conductscience.org/library/papers/3219277 | PubMed |
| 3139316 | Pharmacokinetics of thio-TEPA at two different doses. | Cancer Chemother Pharmacol | 1988 | https://conductscience.org/library/papers/3139316 | PubMed |
| 3105905 | Single and repeated dose pharmacokinetics of thio-TEPA in patients treated for ovarian carcinoma. | Cancer Chemother Pharmacol | 1987 | https://conductscience.org/library/papers/3105905 | PubMed |
| 2426218 | Activity of 2-fluoro-Ara AMP against gynecologic tumors in the soft agar assay. | Invest New Drugs | 1986 | https://conductscience.org/library/papers/2426218 | PubMed |
| 1451231 | Antitumor activity of treosulfan against human breast carcinomas. | Cancer Chemother Pharmacol | 1992 | https://conductscience.org/library/papers/1451231 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6791675
GET https://conductscience.org/api/papers/v1/6791675/references?page=2